x

Prime Medicine, Inc. (Nasdaq:PRME)

Health Care/Life Sciences • Biotechnology
CIK 1894562
Company

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Address
60 First Street
Cambridge, Massachusetts 02141-2300
Employees
234
Stock Info
Close
$2.3100
Day Range
2.1500 - 2.3250
52 Week Range
2.1200 - 8.5800
Average volume
1.08M
Short Interest
18.06M (02/14/25)
% of Float Shorted
34.78%
Market Cap
$302.98M
Revenue
N/A
Net Income
-$198.13M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$1.6972
Yield
0.00%
Dividend
$0.8000
Ex-Dividend Date
Sep 10, 2019
Key Executives
Board Of Directors
President, Chief Executive Officer & Director
Keith M. Gottesdiener
Director
Jeffrey D. Marrazzo
Independent Director
Michael Anthony Kelly
SEC filings
DateFormEvent
13 Dec, 2024 S-3
9 Dec, 2024 4
9 Dec, 2024 4
9 Dec, 2024 4
22 Nov, 2024 SC 13D/A
12 Nov, 2024 SC 13G/A
12 Nov, 2024 10-Q
12 Nov, 2024 8-K
24 Oct, 2024 8-K
10 Oct, 2024 4
4 Oct, 2024 SC 13G
30 Sep, 2024 8-K
8 Aug, 2024 8-K
8 Aug, 2024 10-Q
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
12 Jun, 2024 8-K
7 Jun, 2024 4
21 May, 2024 DEFA14A
21 May, 2024 8-K
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
10 May, 2024 10-Q
10 May, 2024 8-K
29 Apr, 2024 DEFA14A
29 Apr, 2024 DEF 14A
29 Apr, 2024 ARS
19 Apr, 2024 PRE 14A
4 Mar, 2024 4
1 Mar, 2024 S-8
1 Mar, 2024 10-K
1 Mar, 2024 8-K
29 Feb, 2024 3
29 Feb, 2024 SC 13G/A
27 Feb, 2024 4
23 Feb, 2024 4
23 Feb, 2024 4
23 Feb, 2024 4
23 Feb, 2024 4
23 Feb, 2024 4
22 Feb, 2024 SC 13D
20 Feb, 2024 4
20 Feb, 2024 4
20 Feb, 2024 4
16 Feb, 2024 8-K
16 Feb, 2024 424B5
15 Feb, 2024 FWP
14 Feb, 2024 424B5
14 Feb, 2024 8-K
9 Feb, 2024 SC 13G/A
9 Feb, 2024 SC 13G/A
8 Jan, 2024 8-K
5 Jan, 2024 8-K
5 Jan, 2024 8-K
14 Nov, 2023 4
13 Nov, 2023 EFFECT
9 Nov, 2023 CORRESP
7 Nov, 2023 UPLOAD
3 Nov, 2023 8-K
3 Nov, 2023 10-Q
3 Nov, 2023 S-3
7 Aug, 2023 10-Q
7 Aug, 2023 8-K
26 Jul, 2023 4/A
25 Jul, 2023 4
22 Jun, 2023 4
16 Jun, 2023 4
16 Jun, 2023 8-K
16 Jun, 2023 4
16 Jun, 2023 4
16 Jun, 2023 4
16 Jun, 2023 4
16 Jun, 2023 4
15 Jun, 2023 4
13 Jun, 2023 4
12 Jun, 2023 144
9 Jun, 2023 4
7 Jun, 2023 4
5 Jun, 2023 144
2 Jun, 2023 4
31 May, 2023 4
30 May, 2023 144
26 May, 2023 4
24 May, 2023 4
22 May, 2023 4
18 May, 2023 4
18 May, 2023 144
17 May, 2023 8-K
16 May, 2023 4
12 May, 2023 3
12 May, 2023 4
12 May, 2023 4
11 May, 2023 DEFA14A
11 May, 2023 10-Q
11 May, 2023 8-K
11 May, 2023 8-K
10 May, 2023 4
8 May, 2023 144
28 Apr, 2023 DEFA14A
28 Apr, 2023 ARS
28 Apr, 2023 DEF 14A
20 Apr, 2023 4
20 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
10 Mar, 2023 8-K/A
9 Mar, 2023 10-K
9 Mar, 2023 S-8
9 Mar, 2023 8-K
13 Feb, 2023 SC 13G
10 Feb, 2023 SC 13G
9 Feb, 2023 SC 13G/A
7 Feb, 2023 SC 13G
9 Jan, 2023 8-K
14 Nov, 2022 10-Q
26 Oct, 2022 4
26 Oct, 2022 4
26 Oct, 2022 4
26 Oct, 2022 SC 13G
26 Oct, 2022 4
26 Oct, 2022 4
26 Oct, 2022 4
24 Oct, 2022 3/A
24 Oct, 2022 8-K
21 Oct, 2022 424B4 IPO completed
21 Oct, 2022 4
21 Oct, 2022 4
21 Oct, 2022 4
20 Oct, 2022 FWP
19 Oct, 2022 EFFECT
19 Oct, 2022 3
19 Oct, 2022 3
19 Oct, 2022 3
19 Oct, 2022 3
19 Oct, 2022 3
19 Oct, 2022 3
19 Oct, 2022 3
19 Oct, 2022 3
19 Oct, 2022 3
19 Oct, 2022 3
19 Oct, 2022 3
19 Oct, 2022 S-8
19 Oct, 2022 S-1MEF
19 Oct, 2022 CERT
19 Oct, 2022 3
19 Oct, 2022 3
19 Oct, 2022 3
19 Oct, 2022 3
19 Oct, 2022 3
19 Oct, 2022 SEC STAFF
17 Oct, 2022 FWP
17 Oct, 2022 CORRESP
17 Oct, 2022 S-1/A
17 Oct, 2022 CORRESP
17 Oct, 2022 8-A12B
17 Oct, 2022 CORRESP
14 Oct, 2022 UPLOAD
13 Oct, 2022 CORRESP
13 Oct, 2022 S-1/A
7 Oct, 2022 CORRESP
30 Sep, 2022 UPLOAD
23 Sep, 2022 S-1
5 Aug, 2022 DRS/A
6 May, 2022 DRS/A
11 Apr, 2022 SEC STAFF
8 Apr, 2022 DRS/A
8 Apr, 2022 DRSLTR
30 Mar, 2022 UPLOAD
25 Mar, 2022 DRS/A
25 Mar, 2022 DRSLTR
15 Mar, 2022 UPLOAD
7 Mar, 2022 DRS/A
7 Mar, 2022 DRSLTR
17 Feb, 2022 UPLOAD
4 Feb, 2022 DRS/A
4 Feb, 2022 DRSLTR
18 Jan, 2022 UPLOAD
12 Jan, 2022 DRS/A
20 Dec, 2021 DRS
Last update:2025-03-06 12:40:54.275176

Sign Up to Subscribe